This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sanofi-Adventis, others ask US Supreme Court to review Mosaic Health's antitrust case

( March 5, 2026, 23:31 GMT | Official Statement) -- MLex Summary: Sanofi-Adventis, Eli Lilly, Novo Nordisk and AstraZeneca asked the US Supreme Court to hear US antitrust claims against them over diabetes treatments. The companies said that in departing from the settled framework for standing, the Second Circuit converted Illinois Brick from an easily administrable rule into one that can be circumvented through artful pleading. “Indeed, an overcharge theory and a lost profit theory are two ways of describing the same alleged harm—namely, that the defendant’s conduct prevented the plaintiff from buying or selling goods at non-collusive prices,” they said. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections